ID

26311

Description

The Effect of Aspirin on Angiogenesis Proteins in Women on Tamoxifen Therapy; ODM derived from: https://clinicaltrials.gov/show/NCT00727948

Link

https://clinicaltrials.gov/show/NCT00727948

Keywords

Versions (1)
  1. 10/16/17 10/16/17 -
Copyright Holder

See clinicaltrials.gov

Uploaded on

October 16, 2017

DOI

To request one please log in.

License

Creative Commons BY 4.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Breast Cancer NCT00727948

English

Eligibility Breast Cancer NCT00727948

1 forms  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
histologically or cytologically proven breast cancer
Description

Breast Carcinoma

Data type

boolean

Alias
UMLS CUI [1]
C0678222
pre or post-menopausal
Description

Premenopausal state | Postmenopausal state

Data type

boolean

Alias
UMLS CUI [1]
C0232969
UMLS CUI [2]
C0232970
age >18
Description

Age

Data type

boolean

Alias
UMLS CUI [1]
C0001779
completed adjuvant non-hormonal therapy >30 days prior to initiation of study (surgery and/or chemotherapy and/or radiation therapy)
Description

Adjuvant therapy Completed | Exception Hormone Therapy | Operative Surgical Procedures Completed| Chemotherapy Completed | Therapeutic radiology procedure Completed

Data type

boolean

Alias
UMLS CUI [1,1]
C0677850
UMLS CUI [1,2]
C0205197
UMLS CUI [2,1]
C1705847
UMLS CUI [2,2]
C0279025
UMLS CUI [3,1]
C0543467
UMLS CUI [3,2]
C0205197
UMLS CUI [4,1]
C0392920
UMLS CUI [4,2]
C0205197
UMLS CUI [5,1]
C1522449
UMLS CUI [5,2]
C0205197
platelet count and hemoglobin within normal ranges for local lab within 30 days of initiation of study therapy
Description

Platelet Count measurement | Hemoglobin measurement

Data type

boolean

Alias
UMLS CUI [1]
C0032181
UMLS CUI [2]
C0518015
receiving tamoxifen therapy for at least 90 days prior to initiation of study therapy, and is expected to continue that therapy for the duration of the study (75 days)
Description

Tamoxifen

Data type

boolean

Alias
UMLS CUI [1]
C0039286
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
chemotherapy, radiation therapy or surgery within 30 days of study therapy
Description

Chemotherapy Regimen | Therapeutic radiology procedure | Operative Surgical Procedures

Data type

boolean

Alias
UMLS CUI [1]
C0392920
UMLS CUI [2]
C1522449
UMLS CUI [3]
C0543467
current use of aspirin, anti-platelet or anti-coagulation agents on a continuous basis
Description

Aspirin | Antiplatelet Agents | Anticoagulants

Data type

boolean

Alias
UMLS CUI [1]
C0004057
UMLS CUI [2]
C0085826
UMLS CUI [3]
C0003280
prior history of gastrointestinal or central nervous system bleeding, or documented or self-reported blood in stools or bright red blood per rectum
Description

Gastrointestinal Hemorrhage | Central nervous system haemorrhage | Blood in stool | Rectal hemorrhage

Data type

boolean

Alias
UMLS CUI [1]
C0017181
UMLS CUI [2]
C3267019
UMLS CUI [3]
C1321898
UMLS CUI [4]
C0267596
Back to the top of the page

Similar models

Eligibility Breast Cancer NCT00727948

1 forms
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
Breast Carcinoma
Item
histologically or cytologically proven breast cancer
boolean
C0678222 (UMLS CUI [1])
Premenopausal state | Postmenopausal state
Item
pre or post-menopausal
boolean
C0232969 (UMLS CUI [1])
C0232970 (UMLS CUI [2])
Age
Item
age >18
boolean
C0001779 (UMLS CUI [1])
Adjuvant therapy Completed | Exception Hormone Therapy | Operative Surgical Procedures Completed| Chemotherapy Completed | Therapeutic radiology procedure Completed
Item
completed adjuvant non-hormonal therapy >30 days prior to initiation of study (surgery and/or chemotherapy and/or radiation therapy)
boolean
C0677850 (UMLS CUI [1,1])
C0205197 (UMLS CUI [1,2])
C1705847 (UMLS CUI [2,1])
C0279025 (UMLS CUI [2,2])
C0543467 (UMLS CUI [3,1])
C0205197 (UMLS CUI [3,2])
C0392920 (UMLS CUI [4,1])
C0205197 (UMLS CUI [4,2])
C1522449 (UMLS CUI [5,1])
C0205197 (UMLS CUI [5,2])
Platelet Count measurement | Hemoglobin measurement
Item
platelet count and hemoglobin within normal ranges for local lab within 30 days of initiation of study therapy
boolean
C0032181 (UMLS CUI [1])
C0518015 (UMLS CUI [2])
Tamoxifen
Item
receiving tamoxifen therapy for at least 90 days prior to initiation of study therapy, and is expected to continue that therapy for the duration of the study (75 days)
boolean
C0039286 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Chemotherapy Regimen | Therapeutic radiology procedure | Operative Surgical Procedures
Item
chemotherapy, radiation therapy or surgery within 30 days of study therapy
boolean
C0392920 (UMLS CUI [1])
C1522449 (UMLS CUI [2])
C0543467 (UMLS CUI [3])
Aspirin | Antiplatelet Agents | Anticoagulants
Item
current use of aspirin, anti-platelet or anti-coagulation agents on a continuous basis
boolean
C0004057 (UMLS CUI [1])
C0085826 (UMLS CUI [2])
C0003280 (UMLS CUI [3])
Gastrointestinal Hemorrhage | Central nervous system haemorrhage | Blood in stool | Rectal hemorrhage
Item
prior history of gastrointestinal or central nervous system bleeding, or documented or self-reported blood in stools or bright red blood per rectum
boolean
C0017181 (UMLS CUI [1])
C3267019 (UMLS CUI [2])
C1321898 (UMLS CUI [3])
C0267596 (UMLS CUI [4])
Back to the top of the page 

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial